
ClearPoint Neuro, Inc.
CLPTNASDAQHealthcare● Active
$13.38
+$0.49(+3.80%)
Market Cap$401260353
P/E Ratio—
52W High$30.1
52W Low$8.27
ClearPoint Neuro, Inc.(CLPT)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CLPT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($25.54M) | ($18.91M) | ($22.09M) | ($16.43M) | ($14.41M) |
| Depreciation & Amort. | $0.98M | $1.90M | $1.51M | $0.78M | $0.69M |
| Stock-Based Comp. | $8.18M | $6.91M | $6.08M | $0.00M | $2.08M |
| Change in Working Capital | ($9.81M) | $1.40M | ($1.40M) | ($4.29M) | ($1.68M) |
| Net Cash from Operations | ($23.93M) | ($8.95M) | ($13.72M) | ($16.17M) | ($12.70M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.52M) | ($0.28M) | ($0.72M) | ($0.25M) | ($0.17M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | ($21.59M) | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $12.00M | $0.00M |
| Net Cash from Investing | $0.61M | ($0.28M) | $8.95M | ($10.74M) | ($0.17M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | ($0.21M) | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $48.09M | ($10.00M) | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $50.18M | $6.19M | $0.30M | $0.41M | $46.88M |
| Free Cash Flow | |||||
| Free Cash Flow | ($24.45M) | ($9.22M) | ($14.44M) | ($16.42M) | ($12.87M) |
| FCF Margin %(computed) | -66.12% | -29.39% | -60.27% | -79.90% | -78.93% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M
深入了解ClearPoint Neuro, Inc.
关于ClearPoint Neuro, Inc.(CLPT)现金流量表
ClearPoint Neuro, Inc. 2025财年经营活动现金流($0.02B),自由现金流($0.02B)(FCF利润率-66.12%),资本支出($0.00B)。
常见问题
CLPT · 4 问ClearPoint Neuro, Inc. 2025财年自由现金流($0.02B),同比down165.0%。
CLPT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10